NCT03642652 is a NA clinical trial of SMS in Colorectal Cancer, sponsored by Meuhedet. Healthcare Organization.

Who is sponsoring NCT03642652?

NCT03642652 is sponsored by Meuhedet. Healthcare Organization.

What drugs are being tested in NCT03642652?

Interventions in NCT03642652: SMS.

What condition does NCT03642652 study?

NCT03642652 studies Colorectal Cancer.

Is NCT03642652 still recruiting?

NCT03642652 is currently completed. Last updated 24 August 2018.

Last reviewed 2018-08-24 · How we verify

NCT03642652

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

SMS Reminders for Positive FOBT Follow-up

Completed NA Last updated 24 August 2018

What this trial tests

NA trial testing SMS in Colorectal Cancer in 470 participants. Completed in 1 May 2017.

Timeline

1 April 2016

Primary endpoint
1 April 2017

1 May 2017

Quick facts

Lead sponsor	Meuhedet. Healthcare Organization
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	470
Start date	1 April 2016
Primary completion	1 April 2017
Estimated completion	1 May 2017

Drugs / interventions tested

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →

Sponsor

Meuhedet. Healthcare Organization

Who can join

Adults 50 to 75, any sex, with Colorectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled trial to examine the effect of 3 mobile telephone text message reminders on followup colonoscopy 120 days after a positive fecal occult blood test among Meuhedet members aged 50-74 who tested positive in 2016.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.
Azulay R, Valinsky L, Hershkowitz F, Magnezi R. · · 2019 · cited 13× · PMID 30720439 · DOI 10.2196/11114

Verify or expand the search:

Other trials of SMS

Trials testing the same drug.

NCT06903091 — Efficacy of Text-messaging on Activity Limitation in People With Chronic Low Back · NA · not yet recruiting
NCT05964842 — Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda · NA · completed
NCT04332172 — Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy · NA · completed
NCT05509270 — Efficacy of Communication Modalities for Promoting Flu Shots · NA · completed
NCT05430451 — Simple Physical Exercise With Instant Messaging Support for Smoking Via "Quit to Win" Contest 2022 (QTW2022) · NA · unknown

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other Meuhedet. Healthcare Organization trials

Trials by the same sponsor.

NCT04632979 — Backward Running on a Negative Slope as a Treatment for Achilles Tendinopathy in Runners · NA · completed
NCT03677167 — The Effect of Barefoot Walking Plantar Chronic Heel Pain · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03642652 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Meuhedet. Healthcare Organization
Last refreshed: 24 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03642652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing